SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Prysmian S.p.A. (PRYMF) trades at a trailing P/E of 33.0, forward P/E of 30.4. Trailing earnings yield is 3.03%, forward earnings yield 3.29%. PEG 0.45 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 30.4 (down from trailing 33.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.45 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.03% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 3.29% as earnings recover.
Overall SharesGrow Score: 57/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PRYMF
Valuation Multiples
P/E (TTM)33.0
Forward P/E30.4
PEG Ratio0.45
Forward PEG3.49
P/B Ratio0.00
P/S Ratio2.14
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.30
Forward EPS (Est.)$4.67
Book Value / Share$0.00
Revenue / Share$66.51
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.03%
Forward Earnings Yield3.29%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.05 |
$7.57B |
$246M |
3.3% |
| 2017 |
$1.11 |
$7.9B |
$241M |
3.1% |
| 2018 |
$0.53 |
$10.16B |
$130M |
1.3% |
| 2019 |
$1.11 |
$11.52B |
$292M |
2.5% |
| 2020 |
$0.68 |
$10.02B |
$178M |
1.8% |
| 2021 |
$1.17 |
$12.74B |
$308M |
2.4% |
| 2022 |
$1.90 |
$16.07B |
$504M |
3.1% |
| 2023 |
$1.82 |
$15.35B |
$529M |
3.4% |
| 2024 |
$2.47 |
$17.03B |
$729M |
4.3% |
| 2025 |
$4.30 |
$19.64B |
$1.27B |
6.5% |
